← Back to Search

Remote PCIT for Disruptive Behavior (AI I-PCIT Trial)

N/A
Waitlist Available
Led By Magdalena Romanowicz, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, approximately 2 years
Awards & highlights

AI I-PCIT Trial Summary

This trial aims to see if remote PCIT therapy with wearables can help children with disruptive behaviors. #mentalhealth

Eligible Conditions
  • Disruptive Behavior

AI I-PCIT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, approximately 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, approximately 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Evaluating parental acceptance of remote PCIT augmented with a Garmin device
How wearing a Garmin watch will help the remote PCIT clinical outcomes
Number of participants able to wear the Garmin watch throughout remote PCIT
Secondary outcome measures
Evaluating clinical improvement from remote PCIT in regards to parental reports of behavior accuracy of indirect behavioral measures from wearable devices to parental ratings
Evaluating clinical improvement from remote PCIT in regards to sleep
Evaluating measured sleep data throughout remote PCIT

AI I-PCIT Trial Design

1Treatment groups
Experimental Treatment
Group I: Wearable Device InterventionExperimental Treatment1 Intervention
An open label, non randomized trial that requires all participants to wear a Garmin watch throughout the course of the trial (~12 weeks).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Remote PCIT augmented with wearable devices
2023
N/A
~10

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,242 Previous Clinical Trials
3,773,479 Total Patients Enrolled
1 Trials studying Disruptive Behavior
100 Patients Enrolled for Disruptive Behavior
Magdalena Romanowicz, MDPrincipal InvestigatorMayo Clinic

Media Library

Remote PCIT augmented with wearable devices Clinical Trial Eligibility Overview. Trial Name: NCT05725525 — N/A
Disruptive Behavior Research Study Groups: Wearable Device Intervention
Disruptive Behavior Clinical Trial 2023: Remote PCIT augmented with wearable devices Highlights & Side Effects. Trial Name: NCT05725525 — N/A
Remote PCIT augmented with wearable devices 2023 Treatment Timeline for Medical Study. Trial Name: NCT05725525 — N/A
~2 spots leftby Jun 2025